SSI (ICAN-ISC workshop)

9
Surgical Site Infec/ons November 2012 Andreas Voss, MD, PhD 1 Andreas Voss iPrevent UMCN & CWZ Nijmegen, The Netherlands OCCUR WITHIN 30 DAYS POST SURGERY UNLESS IMPLANT UP TO 1 YEAR Surgical site infec/ons account for 20% of all nosocomial infec/ons Approximately 35% of surgical opera/ons result in an infec/on 77% of deaths among pa/ents with SSI are directly aQributable to SSI AQributable cost of SSI vary $3,000$29,000 There are many pre-and perioperative factors that determine whether or not a patient will develop a SSI Pa/entrelated Procedurerelated Structurerelated Pa#entrelated Procedurerelated Structurerelated

description

ICAN-ISA workshop on HAI control. Talk on surgical site infections (SSI)

Transcript of SSI (ICAN-ISC workshop)

Page 1: SSI (ICAN-ISC workshop)

Surgical  Site  Infec/ons   November  2012  

Andreas  Voss,  MD,  PhD   1  

Andreas  Voss  iPrevent  

UMCN  &  CWZ  Nijmegen,  The  Netherlands  

OCCUR WITHIN 30 DAYS POST SURGERY

UNLESS IMPLANT UP TO 1 YEAR

¤ Surgical  site  infec/ons  account  for  20%  of  all  nosocomial  infec/ons  

¤ Approximately  3-­‐5%  of  surgical  opera/ons  result  in  an  infec/on  

¤ 77%  of  deaths  among  pa/ents  with  SSI  are  directly  aQributable  to  SSI  

¤ AQributable  cost  of  SSI  vary  -­‐  $3,000-­‐$29,000    

Your are entering the operating theatre

There are many pre-and perioperative factors that determine whether or not

a patient will develop a SSI

¤ Pa/ent-­‐related  

¤ Procedure-­‐related  

¤ Structure-­‐related  

¤ Pa#ent-­‐related  

¤ Procedure-­‐related  

¤ Structure-­‐related  

Page 2: SSI (ICAN-ISC workshop)

Surgical  Site  Infec/ons   November  2012  

Andreas  Voss,  MD,  PhD   2  

¤ Pa/ent-­‐related  

¤ Procedure-­‐related  

¤ Structure-­‐related  

¤ Pa/ent-­‐related  

¤ Procedure-­‐related  

¤ Structure-­‐related  

No  influence  possible  

¤  Age  

¤  Underlying  disease  

¤  Malignancy  

¤  Wound  classifica/on  

¤  Prosthe/c  material  

Influence by hospital •  Laminar  air-­‐flow  •  Steriliza/on  •  Pre-op hospitalization

Influenced by patient

•  BMI >30

•  Nicotine use

•  Malnutrition

•  Infection at remote site

Can & should be influenced

•  Surveillance

•  S. aureus colonization

•  Normothermia/hyperoxia

•  Glucose levels

•  Hair-removal

•  Antimicrobial prophylaxis

•  Skin disinfection

¤  Avoid  shaving  opera/ve  site  

¤ Maintain  Post-­‐op  Glucose  Control  for  Major  Cardiac  Surgery  

¤ Maintain  Post-­‐op  Normothermia  for  Colorectal  Surgery  

¤  Use  Prophylac/c  An/bio/cs  appropriately  

¤  Use  Basic  Preven/ve  Strategies  from  CDC  

² exclude  pa/ents  w/infec/on,  stop  tobacco  use,  keep  OR  doors  closed,  wear  masks,  prepare  skin  w/appropriate  agent.      

hQp://www.ihi.org/IHI/Topics/Pa/entSafety/SurgicalSiteInfec/ons/Changes/  

… or not

Disinfec/on  and  steriliza/on  

Page 3: SSI (ICAN-ISC workshop)

Surgical  Site  Infec/ons   November  2012  

Andreas  Voss,  MD,  PhD   3  

Brandt et al, Ann Surg 2008; 248:695-700.

¤  63  surgical  departments  par/cipa/ng  in  KISS  

¤  >99.000  opera/ons  

¤  Turbulent  +  HEPA  versus  laminar  airflow  +  HEPA  

¤ Mul/variate  analyis  to  comtrol  fot  other  factors  influencing  outcome  (SSI)  

Brandt et al, Ann Surg 2008; 248:695-700.

Significant                              ns                                              ns                                              ns                                              ns                                            ns                          

Brandt et al, Ann Surg 2008; 248:695-700.

Follow-­‐up  study  taking  in  account  the  size  of  the  LAF  plenum  shows  no  difference  in  outcome      

CAN & SHOULD

¤ S.  aureus  coloniza/on  

¤ An/microbial  prophylaxis  

¤ Surveillance  

¤ Normothermia  

¤ Hyperoxia  

¤ Glucose  levels  

¤ Hair-­‐removal  

¤ Skin  disinfec/on  

Page 4: SSI (ICAN-ISC workshop)

Surgical  Site  Infec/ons   November  2012  

Andreas  Voss,  MD,  PhD   4  

¤ S.  aureus  coloniza#on  

¤ An/microbial  prophylaxis  

¤ Surveillance  

¤ Normothermia  

¤ Hyperoxia  

¤ Glucose  levels  

¤ Hair-­‐removal  

¤ Skin  disinfec/on  

Nasal  decoloniza/on  

¤ S.  aureus  coloniza/on  

¤ An#microbial  prophylaxis  

¤ Surveillance  

¤ Normothermia  

¤ Hyperoxia  

¤ Glucose  levels  

¤ Hair-­‐removal  

¤ Skin  disinfec/on  

Classen. NEJM 1992;328:281.

Infec

tions

(%)

Hours From Incision

14/369

5/699 5/1009

2/180 1/81

1/41 1/47

15/441

¤ S.  aureus  coloniza/on  

¤ An/microbial  prophylaxis  

¤ Surveillance  

¤ Normothermia  

¤ Hyperoxia  

¤ Glucose  levels  

¤ Hair-­‐removal  

¤ Skin  disinfec/on  

Page 5: SSI (ICAN-ISC workshop)

Surgical  Site  Infec/ons   November  2012  

Andreas  Voss,  MD,  PhD   5  

¤ Reduc/on  of  Nosocomial              Infec/ons    

Li>le  things  can  have  great  impact  

(on  hygiene)  

year  

No  significant  risk  reduc#on  was  

observed  for  pa#ents  operated  on  during  the  second  and  third  surveillance  years  

%  SSI  

Geubels et al Intern J Qual Health Care 2006;18:127-133

¤ S.  aureus  coloniza/on  

¤ An/microbial  prophylaxis  

¤ Surveillance  

¤ Normothermia  

¤ Hyperoxia  

¤ Glucose  levels  

¤ Hair-­‐removal  

¤ Skin  disinfec/on  

Kurz  et  al.  NEJM  1996;  334:1209-­‐15    

   

Pa/ents  with  colorectal  opera/ons      

sample  

SSI  rate  (%)    

6  %  

19  %  

Normothermia  

Hypothermia    

p=0.009  

200  Pa#ents  

Page 6: SSI (ICAN-ISC workshop)

Surgical  Site  Infec/ons   November  2012  

Andreas  Voss,  MD,  PhD   6  

SSI-­‐rate    Local                    Systemic  

5  (4%)                        8  (6%)  

Control    

19  (14%)  

Melling. Lancet. 2001; 358:876.

*  p  <  0.01  

¤ S.  aureus  coloniza/on  

¤ An/microbial  prophylaxis  

¤ Surveillance  

¤ Normothermia  

¤ Hyperoxia  

¤ Glucose  levels  

¤ Hair-­‐removal  

¤ Skin  disinfec/on  

JAMA 2004; 291:79-87

JAMA 2005; 294:2035-42

•   High  FiO2  (0.80)          during  and  aqer          surgery  •   Colorectal  !  •   General  surgery?  

¤ S.  aureus  coloniza/on  

¤ An/microbial  prophylaxis  

¤ Surveillance  

¤ Normothermia  

¤ Hyperoxia  

¤ Glucose  levels  

¤ Hair-­‐removal  

¤ Skin  disinfec/on  

¤ Postopera/ve  hyperglycemia  is  an  important  independent  risk  factor  for  SSI  in  general  surgery  pa/ents.  

Archives of Surgery 2010;145:858-864]

¤ S.  aureus  coloniza/on  

¤ An/microbial  prophylaxis  

¤ Surveillance  

¤ Normothermia  

¤ Hyperoxia  

¤ Glucose  levels  

¤ Hair-­‐removal  

¤ Skin  disinfec/on  

Page 7: SSI (ICAN-ISC workshop)

Surgical  Site  Infec/ons   November  2012  

Andreas  Voss,  MD,  PhD   7  

 No  Hair      Group  Removal  Depilatory  Shaved  

¤ Number  155  153  246  

¤ Infec/on  rate  0.6%  0.6%  5.6%  

Seropian.  Am  J  Surg.  1971;  121:  251.  

Rasors vs. „Clipping“

OR = 2.02 (CI95 1.21-3.36)

Rasors vs. Depilatory cream

OR = 1.54 (CI95 1.05-2.24)

Tanner  et  al.  Cochrane  Database  Syst  Rev  2006  Jul  19  

¤ Inappropriate:    ² Shaving  

¤ Appropriate:  ² No  hair  removal  at  all  ² Clipping    ² Depilatory  use    

¤ S.  aureus  coloniza/on  

¤ An/microbial  prophylaxis  

¤ Surveillance  

¤ Normothermia  

¤ Hyperoxia  

¤ Glucose  levels  

¤ Hair-­‐removal  

¤ Skin  disinfec#on  

Page 8: SSI (ICAN-ISC workshop)

Surgical  Site  Infec/ons   November  2012  

Andreas  Voss,  MD,  PhD   8  

New results !

NEJM            

Darouiche  et  al    NEJM      2010;362:18-­‐26  

¤ The  overall  rate  SSI  was  significantly  lower  in  the  chlorhexidine–alcohol  group  than  in  the  povidone–iodine  group    (9.5%  vs.  16.1%;  P=0.004)    

¤ Chlorhexidine–alcohol  was  significantly  more  protec/ve  against  

² superficial  incisional  infec/ons  (4.2%  vs.  8.6%,  P=0.008)    

² deep  incisional  infec/ons  (1%  vs.  3%,  P=0.05)    

Darouiche  et  al    NEJM      2010;362:18-­‐26  

¤ Alcoholic  solu/ons  standard  of  care  in  NL  en  other  EU  ² I  miss  the  comparison  with  povidone–iodine-­‐alcohol!  

¤ What  part  of  chlorhexidine–alcohol  works?  

¤ How  important  is  the  CHG  concentra/on  ¤ Landmark  study  that  shows  that  the  choice  of  skin-­‐prep  counts  !  

Darouiche  et  al    NEJM      2010;362:18-­‐26  

Reasons  why  implementa/on  of  effec/ve  IC  measures  in  the  OR  is  complicated  

J  Am  Coll  Surg  2008;  207:810-­‐20  

Page 9: SSI (ICAN-ISC workshop)

Surgical  Site  Infec/ons   November  2012  

Andreas  Voss,  MD,  PhD   9  

What  do  we  need  to  effec/vly  implement  IC  measures  in  the  OR  

¤ People,  /me  and  money  

¤ Strong  leadership    

² To  handle  the  mul/-­‐disciplinary  environment  

² To  ensure  responsibili/es  are  known  to  individual  HCWs    

¤ Pa/ent  safety  culture  

² Survey  and  act  on  process  &  outcome  data  

¤ “Conformity”  of  all  HCWs  ‘opera/ng”  in  and  around  the  OR  ² To  increase  compliance  with  basic  IC  measures  in  OR